- Home
- SXTC vs ECF Comparison
SXTC vs ECF Comparison
Compare SXTC & ECF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- ECF
- Stock Information
- Founded
- SXTC 2005
- ECF 1986
- Country
- SXTC China
- ECF United States
- Employees
- SXTC N/A
- ECF N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- ECF Finance/Investors Services
- Sector
- SXTC Health Care
- ECF Finance
- Exchange
- SXTC Nasdaq
- ECF Nasdaq
- Market Cap
- SXTC 184.5M
- ECF 167.1M
- IPO Year
- SXTC 2019
- ECF N/A
- Fundamental
- Price
- SXTC $1.35
- ECF $11.64
- Analyst Decision
- SXTC
- ECF
- Analyst Count
- SXTC 0
- ECF 0
- Target Price
- SXTC N/A
- ECF N/A
- AVG Volume (30 Days)
- SXTC 244.1K
- ECF 57.7K
- Earning Date
- SXTC 01-01-0001
- ECF 01-01-0001
- Dividend Yield
- SXTC N/A
- ECF 6.42%
- EPS Growth
- SXTC N/A
- ECF N/A
- EPS
- SXTC N/A
- ECF 0.46
- Revenue
- SXTC $1,740,907.00
- ECF N/A
- Revenue This Year
- SXTC N/A
- ECF N/A
- Revenue Next Year
- SXTC N/A
- ECF N/A
- P/E Ratio
- SXTC N/A
- ECF $17.61
- Revenue Growth
- SXTC N/A
- ECF N/A
- 52 Week Low
- SXTC $0.95
- ECF $7.02
- 52 Week High
- SXTC $7.84
- ECF $8.91
- Technical
- Relative Strength Index (RSI)
- SXTC 47.18
- ECF 39.79
- Support Level
- SXTC $1.32
- ECF $11.55
- Resistance Level
- SXTC $1.65
- ECF $11.93
- Average True Range (ATR)
- SXTC 0.13
- ECF 0.28
- MACD
- SXTC 0.00
- ECF -0.09
- Stochastic Oscillator
- SXTC 12.77
- ECF 20.00
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About ECF Ellsworth Growth and Income Fund Ltd.
Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.